Impact of effect of Ayurvedic treatment on novel Corona virus disease
Not Applicable
Completed
- Conditions
- Health Condition 1: J969- Respiratory failure, unspecified
- Registration Number
- CTRI/2020/05/025273
- Lead Sponsor
- Patanjali Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Asymptomatic patients
Mildly symptomatic patients
Moderately symptomatic patients
Age 15-80 years of age
Patients able to give Informed consent and follow instructions
Agree to follow at 14 days and 30 days after testing positive for COVID-19
Exclusion Criteria
Severely symptomatic patients (SaO2 <90%)
Acute Respiratory Distress Syndrome (ARDS)
Life expectancy less than 1 year due to other co-morbid conditions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Virological Clearance as measured by RT PCR of nasopharyngeal swabTimepoint: Baseline, 3 Days, 7 Days, 14 Days
- Secondary Outcome Measures
Name Time Method Conversion from Symptomatic to Asymptomatic patient <br/ ><br> <br/ ><br>Reduction in C-reactive protein, ESR & IL-6 <br/ ><br> <br/ ><br>Improvement in heamatological parameters eg Total Leucocyte count <br/ ><br> <br/ ><br>Safety analysisTimepoint: Baseline, 3 Days, 7 Days, 14 Days